Evidence map›Paper›PMID 39845347›Full record

ArticleFrontiers in neuroinformatics2024

Deep CNN ResNet-18 based model with attention and transfer learning for Alzheimer's disease detection.

Sofia Biju Francis, Jai Prakash Verma

Abstract read
In one paragraph

Article in Frontiers in neuroinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sofia Biju FrancisDepartment of Computer Science and Engineering, Institute of Technology, Nirma University, Gujarat, India.
Jai Prakash VermaDepartment of Computer Science and Engineering, Institute of Technology, Nirma University, Gujarat, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The prevalence of age-related brain issues has risen in developed countries because of changes in lifestyle. Alzheimer's disease leads to a rapid and irreversible decline in cognitive abilities by damaging memory cells. Methods: A ResNet-18-based system is proposed, integrating Depth Convolution with a Squeeze and Excitation (SE) block to minimize tuning parameters. This design is based on analyses of existing deep learning architectures and feature extraction techniques. Additionally, pre-trained ResNet-18 models were created with and without the SE block to compare ROC and accuracy values across different hyperparameters. Results: The proposed model achieved ROC values of 95% for Alzheimer's Disease (AD), 95% for Cognitively Normal (CN), and 93% for Mild Cognitive Impairment (MCI), with a maximum test accuracy of 88.51%. However, the pre-trained model with SE had 93.26% accuracy and ROC values of 98%, 99%, and 98%, while the model without SE had 94%, 97%, and 94% ROC values and 92.41% accuracy. Discussion: Collecting medical data can be expensive and raises ethical concerns. Small data sets are also prone to local minima issues in the cost function. A scratch model that experiences extensive hyperparameter tuning may end up being either overfitted or underfitted. Class imbalance also reduces performance. Transfer learning is most effective with small, imbalanced datasets, and pre-trained models with SE blocks perform better than others. The proposed model introduced a method to reduce training parameters and prevent overfitting from imbalanced medical data. Overall performance findings show that the suggested approach performs better than the state-of-the-art techniques.

Indexed as

Alzheimer's diseasecognitive deteriorationdepth convolutionResNet-18squeeze and excitationtransfer learning

Identifiers

PMID39845347
PMCPMC11752122

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.